Schedule 13G ownership disclosure

Whitehawk Therapeutics, Inc.

Common stock · CUSIP: 00032Q104

Event date: 2025-08-19

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Coastlands Capital LP

    Shares: 2,819,215.00 · Class: 5.98%

  • Coastlands Capital Partners LP

    Shares: 2,819,215.00 · Class: 5.98%

  • Coastlands Capital GP LLC

    Shares: 2,819,215.00 · Class: 5.98%

  • Coastlands Capital LLC

    Shares: 2,819,215.00 · Class: 5.98%

  • Matthew D. Perry

    Shares: 2,819,215.00 · Class: 5.98%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-003766
Form type
SCHEDULE 13G
Filer
Coastlands Capital LP
CIK
CIK 2068530
Filed
Aug 25, 2025
Reporting period
Aug 19, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub